Elena Quesada-Hernández

Elena Quesada-Hernández

Auto-generated profile, based on publicly available information

Elena Quesada-Hernández

Newbiotechnic (NBT), Bollullos de la Mitación, 41110 Seville, Spain

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Current Biology
Verified
Journal Article
Closed access
EQElena Quesada-Hernández
Elena Quesada-Hernández
LCLuca Caneparo
Luca Caneparo
SSSylvia Schneider
Sylvia Schneider
SWSylke Winkler
Sylke Winkler
MLMichael Liebling
Michael Liebling
CHCarl-Philipp Heisenberg
Carl-Philipp Heisenberg

1 January 2015 in Stem Cells International
Verified
Journal Article
Open access
PDF file
NENatalia Escacena
Natalia Escacena
EQElena Quesada-Hernández
Elena Quesada-Hernández
Vivian Capilla-GonzalezVivian Capilla-Gonzalez
Vivian Capilla-Gonzalez
Bernat SoriaBernat Soria
Bernat Soria
Abdelkrim HmadchaAbdelkrim Hmadcha
Abdelkrim Hmadcha
Mesenchymal stromal cells (MSCs) have been established as promising candidate sources of universal donor cells for cell therapy due to their contributions to tissue and organ homeostasis, repair, and support by self-renewal and multidifferentiation, as well as by their anti-inflammatory, antiproliferative, immunomodulatory, trophic, and proangiogenic properties. Various diseases have been treated by MSCs in animal models. Additionally, hundreds of clinical trials related to the potential benefits of MSCs are in progress. However, although all MSCs are considered suitable to exert these functions, dissimilarities have been found among MSCs derived from different tissues. The same levels of efficacy and desired outcomes have not always been achieved in the diverse studies that have been performed thus far. Moreover, autologous MSCs can be affected by the disease status of patients, compromising their use. Therefore, collecting information regarding the characteristics of MSCs obtained from different sources and the influence of the host (patient) medical conditions on MSCs is important for assuring the safety and efficacy of cell-based therapies. This review provides relevant information regarding factors to consider for the clinical application of MSCs.

1 September 2014 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
CHRISTIAN CLAUDE LACHAUDCHRISTIAN CLAUDE LACHAUD
CHRISTIAN CLAUDE LACHAUD
FSFelipe Soria
Felipe Soria
NENatalia Escacena
Natalia Escacena
EQElena Quesada-Hernández
Elena Quesada-Hernández
AHAbdelkrim Hmadcha
Abdelkrim Hmadcha
BSBernat Soria
Bernat Soria
Purpose. To evaluate whether mouse adipose tissue mesothelial cells (ATMCs) share morphologic and biochemical characteristics with mouse corneal endothelial cells (CECs) and to evaluate their capacity to adhere to the decellularized basal membrane of human anterior lens capsules (HALCs) as a potential tissue-engineered surrogate for corneal endothelium replacement. Methods. Adipose tissue mesothelial cells were isolated from the visceral adipose tissue of adult mice, and their expression of several corneal endothelium markers was determined with quantitative RT-PCR, immunofluorescence, and Western blotting. Adipose tissue mesothelial cells were cultured in a mesothelial retaining phenotype medium (MRPM) and further seeded and cultured on top of the decellularized basal membrane of HALCs. ATMC-HALC composites were evaluated by optical microscopy, immunofluorescence, and transmission electron microscopy. Results. Mesothelial retaining phenotype medium–cultured ATMCs express the corneal endothelium markers COL4A2, COL8A2, SLC4A4, CAR2, sodium- and potassium-dependent adenosine triphosphatase (Na+/K+-ATPase), β-catenin, zona occludens-1, and N-cadherin in a pattern similar to that in mouse CECs. Furthermore, ATMCs displayed strong adhesion capacity onto the basal membrane of HALCs and formed a confluent monolayer within 72 hours of culture in MRPM. Ultrastructural morphologic and marker characteristics displayed by ATMC monolayer on HALCs clearly indicated that ATMCs retained their original phenotype of squamous epithelial-like cells. Conclusions. Corneal epithelial cells and ATMCs share morphologic (structural) and marker (functional) similarities. The ATMCs adhered and formed structures mimicking focal adhesion complexes with the HALC basal membrane. Monolayer structure and achieved density of ATMCs support the proposal to use adult human mesothelial cells (MCs) as a possible surrogate for damaged corneal endothelium.

1 March 2015 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
CHRISTIAN CLAUDE LACHAUDCHRISTIAN CLAUDE LACHAUD
CHRISTIAN CLAUDE LACHAUD
FSFelipe Soria
Felipe Soria
NENatalia Escacena
Natalia Escacena
EQElena Quesada-Hernández
Elena Quesada-Hernández
Abdelkrim HmadchaAbdelkrim Hmadcha
Abdelkrim Hmadcha
Bernat SoriaBernat Soria
Bernat Soria